STOCK TITAN
  1. Home
  2. Sec-filings
  3. PFE
  4. [Form 4] PFIZER INC Insider Trading Activity

Pfizer (NYSE: PFE) director gets 7,686 phantom stock units as compensation

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Quincey James reported acquisition or exercise transactions in this Form 4 filing.

PFIZER INC director James Quincey reported a compensation grant of phantom stock units tied to Pfizer common stock. He received 7,686.539 phantom stock units on the reported date at a reference value of $26.67 per unit.

Each unit represents one phantom share of common stock and was granted under the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. These units reflect deferred director compensation and will be settled in cash or common stock, at Quincey’s election, after he retires from the Board. Following this award, his balance under this plan increased to 85,004.077 phantom stock units.

Positive

  • None.

Negative

  • None.
Insider Quincey James
Role null
Type Security Shares Price Value
Grant/Award Phantom Stock Units 7,686.539 $26.67 $205K
Holdings After Transaction: Phantom Stock Units — 85,004.077 shares (Direct, null)
Footnotes (1)
  1. Each unit represents one phantom share of common stock. Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors.
Phantom units granted 7,686.539 units Phantom Stock Units grant on reported transaction date
Reference value per unit $26.67 per unit Transaction price per phantom stock unit
Total phantom units after grant 85,004.077 units Balance of phantom stock units following this transaction
Underlying common stock linkage 1 unit = 1 share Each phantom stock unit represents one phantom share of common stock
Phantom Stock Units financial
"The security reported is described as "Phantom Stock Units"."
Phantom stock units are company promises that pay a cash or stock-equivalent award tied to the firm’s share price or value growth, but they do not issue actual shares. Think of them as a bonus check that moves with the stock like a mirror rather than handing over an ownership slice. Investors care because these awards can affect a company’s future cash obligations, executive incentives and reported expenses without causing share dilution.
Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors financial
"Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors."
deferred director's compensation financial
"These units represent deferred director's compensation that are settled in cash or common stock."
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Quincey James
(Last)(First)(Middle)
66 HUDSON BOULEVARD EAST
ATTN: CORPORATE SECRETARY
(Street)
NEW YORK NEW YORK 10001-2192
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
PFIZER INC [ PFE ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/23/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Phantom Stock Units(1)04/23/2026A7,686.539(2) (3) (3)Common Stock7,686.539$26.6785,004.077D
Explanation of Responses:
1. Each unit represents one phantom share of common stock.
2. Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors.
3. These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors.
/s/ Shanice A. Reid, by power of atty., for James Quincey04/27/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Pfizer (PFE) disclose for director James Quincey?

Pfizer disclosed a compensation-related grant of phantom stock units to director James Quincey. He received 7,686.539 phantom stock units, each tracking one share of Pfizer common stock, as part of a deferred compensation arrangement for non-employee directors.

How many phantom stock units did James Quincey receive and now hold at Pfizer (PFE)?

James Quincey received 7,686.539 phantom stock units in this grant. After the award, his total balance under Pfizer’s director deferred compensation plan rose to 85,004.077 phantom stock units linked to Pfizer common stock value.

What are phantom stock units in the context of Pfizer (PFE)?

At Pfizer, each phantom stock unit represents one phantom share of common stock. These units track the value of the stock but are not actual shares. They are typically settled later in cash or stock, functioning as deferred compensation for eligible participants.

Under which Pfizer (PFE) plan were James Quincey’s phantom stock units granted?

The phantom stock units were granted under the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. This plan provides deferred compensation awards, such as phantom units, to Pfizer’s non-employee board members instead of immediate cash payments.

How and when will James Quincey’s Pfizer (PFE) phantom stock units be settled?

James Quincey’s phantom stock units will be settled after he retires from Pfizer’s Board. At that time, the deferred director compensation represented by the units is paid out, either in cash or Pfizer common stock, depending on his election under the plan terms.